Singular Genomics Systems Inc (OMIC)

Finanzdaten der Singular Genomics Systems Inc-Aktie (OMIC)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.51% 0.462	0.505	0.863	0.765	-
Cost Of Revenue	11.73% 0.527	0.597	0.807	-	-
Gross Profit	29.35% -0.065	-0.092	0.056	-	-
Operating Expenses	11.04% 24.47	27.51	25.43	22.51	24.69
Interest Income/Expense	5.56% 0.285	0.27	0.259	0.243	0.211
Benefits Costs and Expenses	-	-	24.50	-	-
Costs And Expenses	11.05% 25.00	28.11	24.50	-	-
Operating Income/Loss	11.10% -24.54	-27.60	-25.38	-22.53	-24.69
Income/Loss From Continuing Operations Before Tax	101.81% 0.462	-25.58	-23.63	-21.10	-23.79
Income/Loss From Continuing Operations After Tax	12.58% -22.36	-25.58	-23.63	-21.10	-23.79
Net Income/Loss	12.58% -22.36	-25.58	-23.63	-21.10	-23.79
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.92% 73.18	72.51	71.93	0.1466	71.22
Diluted Average Shares	0.92% 73.18	72.51	71.93	0.1466	71.22
Basic Earnings Per Share	11.43% -0.31	-0.35	-0.33	-0.30	-0.33
Diluted Earnings Per Share	11.43% -0.31	-0.35	-0.33	-0.30	-0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-